Generalized eruptive keratoacanthoma of the Grzybowski type: some considerations on treatment and pathogenesis

Int J Dermatol. 2019 Dec;58(12):e242-e245. doi: 10.1111/ijd.14548. Epub 2019 Jun 11.

Authors

Antonella Rotola¹, Dario Musmeci², Valentina Gentili¹, Domenico Reale³, Alessandro Borghi², Roberta Rizzo¹, Monica Corazza²

Affiliations

¹ Department of Medical Sciences, Section of Microbiology and Medical Genetics, University of Ferrara, Ferrara, Italy.
² Department of Medical Sciences, Section of Dermatology and Infectious Diseases, University of Ferrara, Ferrara, Italy.
³ Pathology Division, St Anna University Hospital, Ferrara, Italy.

PMID: 31187482
DOI: 10.1111/ijd.14548

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Acitretin / administration & dosage
Administration, Cutaneous
Administration, Oral
Biopsy
DNA, Viral / isolation & purification
Drug Therapy, Combination / methods
Human papillomavirus 16 / genetics
Human papillomavirus 16 / isolation & purification
Humans
Keratoacanthoma / diagnosis
Keratoacanthoma / drug therapy*
Keratoacanthoma / pathology
Keratoacanthoma / virology
Keratolytic Agents / administration & dosage*
Male
Middle Aged
Papillomavirus Infections / diagnosis
Papillomavirus Infections / drug therapy*
Papillomavirus Infections / pathology
Papillomavirus Infections / virology
Skin / drug effects
Skin / pathology*
Skin / virology
Treatment Outcome
Tretinoin / administration & dosage

Substances

DNA, Viral
Keratolytic Agents
Tretinoin
Acitretin